Literature DB >> 18300358

Development of a survival evaluation model for liver transplant recipients with hepatocellular carcinoma secondary to hepatitis B.

Ming Zhang1, Bo Li, Lu-Nan Yan, Fei Yin, Tian-Fu Wen, Yong Zeng, Ji-Chun Zhao, Yu-Kui Ma.   

Abstract

AIM: To develop a model using easily obtainable, objective, verifiable preoperative parameters, to help evaluate post transplant survival probability for hepatocellular carcinoma (HCC) patients with hepatitis B.
METHODS: We retrospectively examined a cohort of 150 consecutive primary cadaveric liver transplants with HCC in our center over 6 years. Thirteen preoperative biochemical parameters and six tumor-related factors were analyzed to identify their correlation with post transplant survival using the Cox proportional-hazards regression model. The predictive power of a new model and the model for end stage liver disease was compared by the receiver operating characteristic curve.
RESULTS: In univariate analysis, the factors significantly associated with post transplant survival were serum concentrations of albumin, total bilirubin, alkaline phosphatase, alpha-fetoprotein, gamma-glutamyltransferase, aspartate aminotransferase, sodium, tumor diameter and the number of tumor nodules. Multivariate analysis showed alpha-fetoprotein, serum sodium, alkaline phosphatase and the number of tumor nodules were significantly associated with the post transplant outcome. Based on the four variables, we established a new model with a c-statistic of 0.72 which was significantly greater than 0.50 (P = 0.001), and the c-statistic of MELD was 0.59 (P = 0.146).
CONCLUSION: The new model based on four objective tumor-related parameters has the capacity to evaluate the risk of post transplant mortality for HCC patients with hepatitis B.

Entities:  

Mesh:

Year:  2008        PMID: 18300358      PMCID: PMC2690680          DOI: 10.3748/wjg.14.1280

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

1.  A randomized controlled trial of Licartin for preventing hepatoma recurrence after liver transplantation.

Authors:  Jing Xu; Zhong-Yang Shen; Xin-Guo Chen; Qing Zhang; Hui-Jie Bian; Ping Zhu; Hui-Yun Xu; Fei Song; Xiang-Min Yang; Li Mi; Qing-Chuan Zhao; Rong Tian; Qiang Feng; Si-He Zhang; Yu Li; Jian-Li Jiang; Ling Li; Xiao-Ling Yu; Zheng Zhang; Zhi-Nan Chen
Journal:  Hepatology       Date:  2007-02       Impact factor: 17.425

2.  A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.

Authors:  M Malinchoc; P S Kamath; F D Gordon; C J Peine; J Rank; P C ter Borg
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

3.  Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis.

Authors:  S Jonas; W O Bechstein; T Steinmüller; M Herrmann; C Radke; T Berg; U Settmacher; P Neuhaus
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

Review 4.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

5.  Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system.

Authors:  S Iwatsuki; I Dvorchik; J W Marsh; J R Madariaga; B Carr; J J Fung; T E Starzl
Journal:  J Am Coll Surg       Date:  2000-10       Impact factor: 6.113

Review 6.  A decade's studies on metastasis of hepatocellular carcinoma.

Authors:  Zhao-You Tang; Sheng-Long Ye; Yin-Kun Liu; Lun-Xiu Qin; Hui-Chuan Sun; Qin-Hai Ye; Lu Wang; Jian Zhou; Shuang-Jian Qiu; Yan Li; Xue-Ning Ji; Hu Liu; Jing-Ling Xia; Zhi-Quan Wu; Jia Fan; Zeng-Chen Ma; Xin-Da Zhou; Zhi-Ying Lin; Kang-Da Liu
Journal:  J Cancer Res Clin Oncol       Date:  2003-12-18       Impact factor: 4.553

7.  Influence of prognostic factors on the outcome of liver transplantation for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis.

Authors:  Massimo Del Gaudio; Gian Luca Grazi; Alfonso Principe; Matteo Ravaioli; Giorgio Ercolani; Matteo Cescon; Giovanni Varotti; Andrea Gardini; Antonino Cavallari
Journal:  Hepatogastroenterology       Date:  2004 Mar-Apr

8.  Results of the first year of the new liver allocation plan.

Authors:  Richard B Freeman; Russell H Wiesner; Erick Edwards; Ann Harper; Robert Merion; Robert Wolfe
Journal:  Liver Transpl       Date:  2004-01       Impact factor: 5.799

9.  Poor prognostic factors of hepatectomy in patients with resectable small hepatocellular carcinoma and cirrhosis.

Authors:  Toshia Ochiai; Teruhisa Sonoyama; Daisuke Ichikawa; Hitoshi Fujiwara; Kazuma Okamoto; Chohei Sakakura; Yuji Ueda; Eigo Otsuji; Hirosumi Itoi; Akeo Hagiwara; Hisakazu Yamagishi
Journal:  J Cancer Res Clin Oncol       Date:  2004-02-10       Impact factor: 4.553

10.  Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease.

Authors:  Adnan Said; John Williams; Jeremy Holden; Patrick Remington; Ronald Gangnon; Alexandru Musat; Michael R Lucey
Journal:  J Hepatol       Date:  2004-06       Impact factor: 25.083

View more
  1 in total

Review 1.  Heme oxygenase-1 system and gastrointestinal tumors.

Authors:  Xiao Zhu; Wen-Guo Fan; Dong-Pei Li; Marie C M Lin; Hsiangfu Kung
Journal:  World J Gastroenterol       Date:  2010-06-07       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.